For many people struggling with treatment-resistant depression, the thought of committing to 6-9 weeks of daily TMS appointments feels impossible. Work schedules, family responsibilities, and travel distances create barriers that leave countless individuals unable to access this life-changing treatment. What if that entire timeline could be compressed into a single day?
Revolutionary accelerated TMS protocols are transforming depression treatment by delivering what traditionally took months in just 24 hours. These breakthrough approaches show promising success rates in early studies while eliminating the time commitment that has prevented so many from getting help.
Key takeaway:
Single-day TMS protocols compress traditional 6-week depression treatment into 24 hours using accelerated intermittent theta burst stimulation, with preliminary studies showing promising remission rates while eliminating the time commitment barrier that prevents many from accessing treatment.
The Time Barrier That Leaves People Behind
Traditional TMS typically requires patients to visit a clinic five days a week for 4-6 weeks, totaling approximately 20-30 sessions. While effective, this schedule creates significant obstacles for many who need help most.
Working professionals can’t take that much time away from their jobs. Parents struggle to arrange childcare for daily appointments. People in rural areas face hours of driving each day just to reach a treatment center. These practical challenges mean that despite TMS being FDA-approved and highly effective, many people simply can’t access it.
The result is treatment abandonment before people even start. Research shows that scheduling barriers are among the top reasons people decline TMS therapy, even when they desperately want relief from depression. The very people who might benefit most from this breakthrough treatment are often those least able to commit to the traditional timeline.
This accessibility gap has driven scientists to ask a crucial question: what if we could deliver the same therapeutic benefit in a fraction of the time?
How Single-Day TMS Delivers Months of Treatment in Hours
The breakthrough came from understanding how the brain’s neuroplasticity windows work during TMS stimulation. Scientists discovered that by timing sessions strategically, they could potentially maximize the brain’s ability to form new neural pathways in a condensed timeframe.
Single-day protocols deliver up to 20 TMS sessions over approximately 9-10 hours, using a technique called intermittent theta burst stimulation (iTBS). These investigational approaches are designed to work with the brain’s natural learning rhythms, allowing for intensive treatment in research settings.
Advanced neuronavigation systems precisely target the dorsolateral prefrontal cortex, often using personalized brain imaging to customize treatment for each individual. Some experimental protocols enhance effectiveness by combining TMS with investigational medications like d-cycloserine and lisdexamfetamine, though these remain off-label research approaches.
The Stanford SAINT Protocol
Stanford University’s SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy) protocol represents one of the most studied accelerated approaches. This investigational method delivers multiple iTBS sessions per day over five consecutive days.
Early studies of the SAINT protocol reported high response rates in small samples, though these results await broader replication in larger controlled trials. The precision targeting combined with accelerated scheduling shows promise for reducing treatment time while maintaining effectiveness.
UCLA’s 5×5 Protocol
UCLA’s innovative 5×5 protocol delivers five TMS sessions per day for five consecutive days. UCLA reports that up to eight in ten patients experience symptom relief with this approach, though full remission rates have not yet been published in peer-reviewed studies.
The 5×5 method allows patients to complete treatment in just one work week, making it far more accessible than traditional schedules while providing intensive stimulation in a research setting.
Promising Success Rates in Early Research
A recent case series of the single-day ONE-D protocol reported encouraging outcomes in 32 adults with treatment-resistant depression: approximately 90% response rate and 74% remission rate at six weeks post-treatment. While these results are promising, they come from a small, uncontrolled study and require replication in larger trials.
UCLA’s 5×5 protocol shows up to 80% symptom relief according to their clinical reports, though specific remission percentages await peer-reviewed publication. These outcomes suggest potential comparable effectiveness to traditional depression treatment while requiring just five days instead of 6-9 weeks.
Preliminary evidence suggests benefits may persist for months after treatment, but long-term durability beyond 3-6 months remains under study. Early follow-up data indicates sustained mood improvements, though more comprehensive research is needed to establish lasting effectiveness.
Early reports of intensive TMS schedules show acceptable safety and tolerability in small samples, but larger studies and long-term safety data are still needed. Side effects remain generally mild and tolerable, including headache and scalp discomfort, though rare serious risks exist as with traditional TMS.
Who Benefits Most from Accelerated TMS
Treatment-resistant depression remains the primary indication for accelerated TMS protocols. People who haven’t responded to multiple antidepressants or traditional therapy may find renewed hope through these intensive investigational approaches.
Recent FDA developments have expanded TMS access for younger patients. In 2025, BrainsWay’s Deep TMS system received FDA clearance for adjunctive treatment of major depressive disorder in adolescents aged 15-21. Separately, NeuroStar Advanced Therapy was cleared in 2024 for patients aged 15 and older, opening new possibilities for young people struggling with severe depression.
Geographic barriers make accelerated TMS particularly appealing for people living far from treatment centers. Instead of relocating for weeks or making daily long-distance trips, patients could potentially travel once for intensive treatment, then return home to continue their recovery.
People with demanding work schedules or family obligations find accelerated protocols more feasible than traditional timelines. A single day or week of intensive treatment fits better into most people’s lives than months of daily appointments, though these approaches remain largely investigational.
What to Expect During Single-Day Treatment
Single-day TMS treatment begins with comprehensive preparation, including brain imaging for precise targeting and medical evaluation to ensure safety throughout the intensive protocol.
In the ONE-D protocol described in research, the treatment day involves 20 sessions of intermittent theta burst stimulation delivered over approximately 9.5 hours, with 30-minute intervals between treatments that researchers hypothesize may enhance neuroplasticity, though optimal timing remains unproven.
During breaks, patients rest under medical supervision in comfortable clinical settings. Continuous medical oversight ensures safety while monitoring for any side effects throughout the intensive day.
Some research protocols include investigational adjunctive medications like d-cycloserine and lisdexamfetamine, though these remain experimental approaches not part of standard TMS care.
Recovery typically requires 1-2 days of rest, during which mild headaches or fatigue may occur. Most people can return to normal activities within a few days, though individual recovery varies.
Vanguard’s Comprehensive Approach to Intensive Treatment
Vanguard Behavioral Health’s residential and intensive outpatient programs provide ideal settings for innovative treatment approaches. Unlike traditional outpatient clinics, Vanguard offers 24/7 medical supervision and comprehensive support throughout intensive treatment protocols.
The integration of advanced treatments with dual diagnosis care addresses both depression and any co-occurring substance use disorders simultaneously. This comprehensive approach recognizes that effective treatment must address all aspects of mental health, not just individual symptoms.
Master’s-level therapists work alongside medical professionals to provide emotional support and coping strategies throughout intensive treatment processes. Many staff members have lived experience with recovery, creating genuine understanding and connection with patients.
Vanguard’s holistic approach extends beyond individual treatments to include group therapy, individual counseling, and family support services. This comprehensive framework helps patients build lasting recovery skills while accessing breakthrough medical treatments.
The residential setting eliminates logistical concerns about transportation, meals, and accommodation during intensive treatment. Patients can focus entirely on their healing while receiving professional care in a supportive environment designed specifically for recovery.
Frequently Asked Questions
Are accelerated TMS protocols as effective as traditional treatment?
Preliminary research suggests promising effectiveness, with some small studies reporting high response rates. However, accelerated TMS protocols are largely investigational at present, and the FDA has not specifically cleared all accelerated regimens. More research is needed to establish equivalency to traditional approaches.
Who is a candidate for accelerated TMS?
People with treatment-resistant depression who haven’t responded to multiple medications or therapies may be candidates for investigational protocols. Patients must be medically stable and able to tolerate intensive treatment. Participation typically requires enrollment in research studies or specialized clinical programs.
Will insurance cover accelerated TMS treatment?
Coverage varies significantly by insurance plan and provider. While traditional TMS has established coverage patterns, accelerated protocols may require prior authorization or appeal processes since many remain investigational. Reimbursement is currently limited for off-label accelerated approaches.
Are there more side effects with intensive treatment?
Early reports show acceptable safety and tolerability in small samples, with side effect profiles similar to traditional TMS. However, larger controlled studies are needed to fully establish the safety profile of intensive schedules across broader populations.
How long do results from accelerated TMS last?
Preliminary evidence suggests benefits may persist for months after treatment, but long-term durability beyond 3-6 months remains under study. Some patients may benefit from maintenance sessions, and comprehensive treatment programs offer multiple therapeutic options for sustained improvement.
What’s the current research status of these protocols?
Most accelerated TMS protocols remain investigational, with promising early results requiring replication in larger controlled trials. While some approaches show encouraging outcomes in small studies, broader adoption awaits more comprehensive research and potential regulatory approval.
Key Takeaways
- Single-day TMS protocols compress traditional treatment timelines using accelerated intermittent theta burst stimulation
- Preliminary studies show promising response rates, though results require replication in larger trials
- Treatment eliminates scheduling barriers that prevent many people from accessing traditional TMS
- Most accelerated approaches remain investigational, with limited insurance coverage currently available
- Comprehensive treatment settings provide medical supervision and holistic support during intensive protocols
- People with treatment-resistant depression and geographic or scheduling barriers may benefit most from these emerging approaches
Interested in exploring innovative depression treatment approaches? Vanguard Behavioral Health combines evidence-based treatments with comprehensive residential care, providing the medical supervision and holistic support needed for intensive therapeutic interventions.
Call (866) 425-1912 to learn about advanced treatment options and begin your path to lasting recovery.
